Gujarat Terce Laboratories Ltd Intrinsic Value

GUJTERC · Healthcare · Current price ₹39.25

Full stock page
DocStoX fair value
₹20
low confidence
Current price
₹39
Upside to fair value
-49.0%
Verdict
Avoid
Quality score
4.4 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with Gujarat Terce Laboratories Ltd's latest numbers.

Is Gujarat Terce Laboratories Ltd undervalued?

DocStoX estimates the fair value of Gujarat Terce Laboratories Ltd at ₹20 per share, versus the current market price of ₹39. That puts the stock about -49.0% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 1 independent method: Residual income (₹20). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹17 (bear) to ₹20 (base) to ₹23 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹39 versus an intrinsic value of ₹20, Gujarat Terce Laboratories Ltd currently offers -49.0% of negative margin (i.e. a premium).

More on Gujarat Terce Laboratories Ltd

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.